Literature DB >> 23033386

Impaired mesopic visual acuity in eyes with early age-related macular degeneration.

María C Puell1, Ana R Barrio, Catalina Palomo-Alvarez, Fernando J Gómez-Sanz, Amaya Clement-Corral, María J Pérez-Carrasco.   

Abstract

PURPOSE: To determine photopic and mesopic distance high-contrast visual acuity (HC-VA) and low-contrast visual acuity (LC-VA) in eyes with early age-related macular degeneration (AMD).
METHODS: Measurements were made in 22 subjects with early AMD and 28 healthy control subjects. Inclusion criteria included a photopic HC-VA of 20/25 or better. Distance VA was measured using HC (96%) and LC (10%) Bailey-Lovie logMAR letter charts under photopic (85 cd/m(2)) and mesopic (0.1-0.2 cd/m(2)) luminance conditions.
RESULTS: Mean mesopic distance HC-VA and LC-VA were significantly worse (0.1 logMAR and 0.28 logMAR, respectively) in the early AMD group than in the control group. Under mesopic conditions, the mean difference between LC-VA and HC-VA was significantly greater in the early AMD (0.45 logMAR) than the control group (0.27 logMAR). Mean differences between mesopic versus photopic HC-VA and mesopic versus photopic LC-VA were significantly greater in the early AMD than the control group (0.13 and 0.32 logMAR of difference between the means, respectively). Sensitivity and specificity were significantly greater for mesopic LC-VA than for mesopic HC-VA (Receiver Operating Characteristics, area under the curve [AUC], 0.94 ± 0.030 and 0.76 ± 0.067, respectively). AUC values for photopic HC-VA and LC-VA were below 0.70.
CONCLUSIONS: Visual acuity testing under low luminance conditions emerged as an optimal quantitative measure of retinal function in early AMD.

Entities:  

Mesh:

Year:  2012        PMID: 23033386     DOI: 10.1167/iovs.11-8649

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

Review 1.  Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.

Authors:  Catherine Bowes Rickman; Sina Farsiu; Cynthia A Toth; Mikael Klingeborn
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

2.  Repeatability of mesopic visual acuity measurements using high- and low-contrast ETDRS letter charts.

Authors:  Ana Barrio; Beatriz Antona; María C Puell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-09       Impact factor: 3.117

3.  Mesopic visual acuity is less crowded.

Authors:  František Pluháček; John Siderov
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-05-28       Impact factor: 3.117

4.  VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION.

Authors:  Arthika Chandramohan; Sandra S Stinnett; John T Petrowski; Stefanie G Schuman; Cynthia A Toth; Scott W Cousins; Eleonora M Lad
Journal:  Retina       Date:  2016-05       Impact factor: 4.256

5.  Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.

Authors:  Kimberly J Cocce; Sandra S Stinnett; Ulrich F O Luhmann; Lejla Vajzovic; Anupama Horne; Stefanie G Schuman; Cynthia A Toth; Scott W Cousins; Eleonora M Lad
Journal:  Am J Ophthalmol       Date:  2018-03-15       Impact factor: 5.258

6.  Low Light Exposure and Physical Activity in Older Adults With and Without Age-Related Macular Degeneration.

Authors:  Mahesh K Dev; Alex A Black; Damian Cuda; Joanne M Wood
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283

Review 7.  THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.

Authors:  David S Boyer; Ursula Schmidt-Erfurth; Menno van Lookeren Campagne; Erin C Henry; Christopher Brittain
Journal:  Retina       Date:  2017-05       Impact factor: 4.256

8.  Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR.

Authors:  Jan H Terheyden; Frank G Holz; Steffen Schmitz-Valckenberg; Anna Lüning; Matthias Schmid; Gary S Rubin; Hannah Dunbar; Adnan Tufail; David P Crabb; Alison Binns; Clara I Sánchez; Carel Hoyng; Philippe Margaron; Nadia Zakaria; Mary Durbin; Ulrich Luhmann; Parisa Zamiri; José Cunha-Vaz; Cecília Martinho; Sergio Leal; Robert P Finger
Journal:  Trials       Date:  2020-07-18       Impact factor: 2.279

9.  Visual Function in Older Eyes in Normal Macular Health: Association with Incident Early Age-Related Macular Degeneration 3 Years Later.

Authors:  Cynthia Owsley; Mark E Clark; Carrie E Huisingh; Christine A Curcio; Gerald McGwin
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04       Impact factor: 4.799

10.  Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration.

Authors:  Atalie C Thompson; Ulrich F O Luhmann; Sandra S Stinnett; Lejla Vajzovic; Anupama Horne; Cynthia A Toth; Scott W Cousins; Eleonora M Lad
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.